Machine Learning-Based Early Warning Systems for Acute Care Utilization During Systemic Therapy for Cancer
Robert C Grant1,2,3, Jiang Chen He1,2, Ferhana Khan4
11Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Journal of the National Comprehensive Cancer Network : JNCCN
|October 19, 2023
Summary
A new machine learning warning system can predict acute care needs in cancer patients undergoing systemic therapy. This tool aims to improve preventive interventions and personalize cancer treatment by identifying high-risk individuals.
Area of Science:
- Oncology
- Health Informatics
- Machine Learning
Background:
- Emergency department visits and hospitalizations are common during cancer systemic therapy.
- A longitudinal warning system was developed to predict acute care utilization.
Purpose of the Study:
- To develop and evaluate a machine learning-based warning system for predicting acute care use in cancer patients receiving systemic therapy.
- To identify key features that predict the need for acute care interventions.
Main Methods:
- A retrospective population-based cohort of 105,129 patients receiving intravenous systemic therapy for nonhematologic cancers was analyzed.
- Predictive models incorporated static (demographics, cancer type) and dynamic (symptoms, lab values) features.
- The system predicted the probability of acute care utilization within 30 days post-treatment.
Main Results:
- The developed ensemble model achieved an area under the receiver operating characteristic curve of 0.742 in the test cohort.
- Key predictors included prior acute care use, treatment regimen, and laboratory test results.
- The system could flag a significant portion of acute care events but showed underestimation for certain regimens and populations.
Conclusions:
- Machine learning warning systems show promise in identifying cancer patients at risk for acute care utilization.
- These systems can support preventive interventions and tailored treatment strategies.
- Further research is needed to address potential biases and prospectively evaluate system impact.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer Survival Analysis
357
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
357
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


